Financhill
Buy
70

CNP Quote, Financials, Valuation and Earnings

Last price:
$38.90
Seasonality move :
1.79%
Day range:
$38.56 - $39.04
52-week range:
$25.41 - $39.18
Dividend yield:
2.14%
P/E ratio:
26.09x
P/S ratio:
2.82x
P/B ratio:
2.32x
Volume:
3.2M
Avg. volume:
6.3M
1-year change:
32.02%
Market cap:
$25.4B
Revenue:
$8.6B
EPS (TTM):
$1.49
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $7.4B $8.4B $9.3B $8.7B $8.6B
Revenue Growth (YoY) -1.93% 12.59% 11.6% -6.71% -0.61%
 
Cost of Revenues $4.5B $5.1B $5.9B $5B $4.7B
Gross Profit $2.9B $3.2B $3.4B $3.7B $4B
Gross Profit Margin 39.49% 38.4% 36.45% 42.39% 46%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$132M -$56M $375M $28M $62M
Operating Expenses $1.7B $1.8B $1.8B $1.9B $2B
Operating Income $1.2B $1.4B $1.6B $1.8B $2B
 
Net Interest Expenses $529M $529M $524M $701M $838M
EBT. Incl. Unusual Items $563M $778M $1.4B $1.1B $1.2B
Earnings of Discontinued Ops. -$1.3B $818M -- -- --
Income Tax Expense $80M $110M $360M $170M $195M
Net Income to Company -$773M $1.5B $1.1B $917M $1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$773M $1.5B $1.1B $917M $1B
 
Basic EPS (Cont. Ops) -$1.79 $2.35 $1.60 $1.37 $1.58
Diluted EPS (Cont. Ops) -$1.79 $2.28 $1.59 $1.37 $1.58
Weighted Average Basic Share $531M $593M $629.4M $630.9M $643.2M
Weighted Average Diluted Share $531M $610M $632.3M $633.2M $644.1M
 
EBITDA $2.3B $2.6B $3.2B $3.2B $3.5B
EBIT $1.1B $1.3B $1.9B $1.8B $2.1B
 
Revenue (Reported) $7.4B $8.4B $9.3B $8.7B $8.6B
Operating Income (Reported) $1.2B $1.4B $1.6B $1.8B $2B
Operating Income (Adjusted) $1.1B $1.3B $1.9B $1.8B $2.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2.5B $2.8B $2.8B $2.6B $2.9B
Revenue Growth (YoY) 17.54% 8.48% 0.58% -5.72% 11.45%
 
Cost of Revenues $1.6B $1.8B $1.8B $1.5B $1.8B
Gross Profit $903M $942M $998M $1.1B $1.2B
Gross Profit Margin 35.45% 34.09% 35.91% 42.86% 39.93%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $22M $410M $12M $16M -$33M
Operating Expenses $450M $465M $457M $507M $517M
Operating Income $453M $477M $541M $616M $649M
 
Net Interest Expenses $146M $157M $150M $204M $238M
EBT. Incl. Unusual Items $329M $730M $403M $428M $378M
Earnings of Discontinued Ops. $83M -- -- -- --
Income Tax Expense $49M $199M $78M $78M $81M
Net Income to Company $363M $531M $325M $350M $297M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $363M $531M $325M $350M $297M
 
Basic EPS (Cont. Ops) $0.56 $0.82 $0.50 $0.55 $0.45
Diluted EPS (Cont. Ops) $0.56 $0.82 $0.49 $0.55 $0.45
Weighted Average Basic Share $552M $629M $630.3M $632.2M $652.2M
Weighted Average Diluted Share $631M $631M $633.1M $634M $653.3M
 
EBITDA $782M $1.2B $872M $995M $979M
EBIT $475M $887M $553M $632M $616M
 
Revenue (Reported) $2.5B $2.8B $2.8B $2.6B $2.9B
Operating Income (Reported) $453M $477M $541M $616M $649M
Operating Income (Adjusted) $475M $887M $553M $632M $616M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $7.8B $8.6B $9.3B $8.5B $8.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.8B $5.3B $5.9B $4.7B $4.9B
Gross Profit $3B $3.2B $3.5B $3.8B $4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $113M $332M -$23M $32M $13M
Operating Expenses $1.7B $1.9B $1.8B $2B $2B
Operating Income $1.3B $1.4B $1.6B $1.8B $2B
 
Net Interest Expenses $528M $540M $517M $755M $872M
EBT. Incl. Unusual Items $860M $1.2B $1.1B $1.1B $1.2B
Earnings of Discontinued Ops. $39M $735M -- -- --
Income Tax Expense $110M $260M $239M $170M $198M
Net Income to Company $789M $1.7B $851M $942M $966M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $789M $1.7B $851M $942M $966M
 
Basic EPS (Cont. Ops) $1.08 $2.58 $1.27 $1.43 $1.49
Diluted EPS (Cont. Ops) $1.07 $2.54 $1.26 $1.42 $1.49
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.6B $3B $2.9B $3.3B $3.5B
EBIT $1.4B $1.7B $1.6B $1.9B $2B
 
Revenue (Reported) $7.8B $8.6B $9.3B $8.5B $8.9B
Operating Income (Reported) $1.3B $1.4B $1.6B $1.8B $2B
Operating Income (Adjusted) $1.4B $1.7B $1.6B $1.9B $2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2.5B $2.8B $2.8B $2.6B $2.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.6B $1.8B $1.8B $1.5B $1.8B
Gross Profit $903M $942M $998M $1.1B $1.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $22M $410M $12M $16M -$33M
Operating Expenses $450M $465M $457M $507M $517M
Operating Income $453M $477M $541M $616M $649M
 
Net Interest Expenses $146M $157M $150M $204M $238M
EBT. Incl. Unusual Items $329M $730M $403M $428M $378M
Earnings of Discontinued Ops. $83M -- -- -- --
Income Tax Expense $49M $199M $78M $78M $81M
Net Income to Company $363M $531M $325M $350M $297M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $363M $531M $325M $350M $297M
 
Basic EPS (Cont. Ops) $0.56 $0.82 $0.50 $0.55 $0.45
Diluted EPS (Cont. Ops) $0.56 $0.82 $0.49 $0.55 $0.45
Weighted Average Basic Share $552M $629M $630.3M $632.2M $652.2M
Weighted Average Diluted Share $631M $631M $633.1M $634M $653.3M
 
EBITDA $782M $1.2B $872M $995M $979M
EBIT $475M $887M $553M $632M $616M
 
Revenue (Reported) $2.5B $2.8B $2.8B $2.6B $2.9B
Operating Income (Reported) $453M $477M $541M $616M $649M
Operating Income (Adjusted) $475M $887M $553M $632M $616M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $147M $230M $74M $90M $24M
Short Term Investments $871M $1.4B $510M $541M $561M
Accounts Receivable, Net $676M $690M $889M $710M $717M
Inventory $500M $608M $876M $770M $714M
Prepaid Expenses $121M -- -- -- --
Other Current Assets $18M $1.5B $1.6B $306M $362M
Total Current Assets $2.9B $7.4B $4.7B $3B $4.4B
 
Property Plant And Equipment $22.4B $23.5B $27.1B $29.9B $32.1B
Long-Term Investments $363M -- -- -- --
Goodwill $4.7B $4.3B $4.3B $4.2B $3.9B
Other Intangibles $50M $44M -- -- --
Other Long-Term Assets $986M $176M $215M $162M $247M
Total Assets $33.5B $37.7B $38.5B $39.7B $43.8B
 
Accounts Payable $853M $1.2B $1.4B $917M $1.3B
Accrued Expenses $145M $136M $159M $236M $274M
Current Portion Of Long-Term Debt $1.9B $545M $2B $1.1B $566M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.4B $1.8B $1B $1.1B $1.3B
Total Current Liabilities $4.8B $4.3B $5.1B $3.9B $4B
 
Long-Term Debt $11.5B $15.6B $14.8B $17.6B $20.4B
Capital Leases -- -- -- -- --
Total Liabilities $25.1B $28.3B $28.5B $30B $33.1B
 
Common Stock $2.4B $799M $799M $6M $6M
Other Common Equity Adj -$90M -$64M -$31M -$35M -$17M
Common Equity $6B $8.6B $9.3B $9.7B $10.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.3B $9.4B $10B $9.7B $10.7B
 
Total Liabilities and Equity $33.5B $37.7B $38.5B $39.7B $43.8B
Cash and Short Terms $1B $1.7B $584M $631M $585M
Total Debt $13.4B $16.1B $16.9B $18.6B $21B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $146M $125M $114M $161M $1.3B
Short Term Investments $848M $720M $548M $458M $640M
Accounts Receivable, Net $780M $943M $874M $675M $869M
Inventory $377M $512M $781M $663M $608M
Prepaid Expenses $646M $100M -- -- --
Other Current Assets -- $1.3B $416M $425M $281M
Total Current Assets $3.2B $4.2B $3.1B $4.3B $4.1B
 
Property Plant And Equipment $22.7B $24.2B $27.6B $29.4B $33.1B
Long-Term Investments $1.2B -- -- -- --
Goodwill $4.7B $4.3B $4.3B $3.9B $3.9B
Other Intangibles -- -- $37M -- --
Other Long-Term Assets $240M $231M $185M $163M $221M
Total Assets $35.9B $35.2B $37.8B $40.2B $44.5B
 
Accounts Payable $797M $1B $934M $753M $1B
Accrued Expenses $119M $116M $152M $208M $235M
Current Portion Of Long-Term Debt $1.8B $1.8B $719M $1B $1.8B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.3B $1.1B $961M $1.1B $1B
Total Current Liabilities $4.3B $4.6B $3.2B $3.4B $4.4B
 
Long-Term Debt $14B $12.1B $15.8B $18.1B $20.4B
Capital Leases -- -- -- -- --
Total Liabilities $27.2B $25.3B $27.4B $30.2B $33.5B
 
Common Stock $2.4B $796M $796M $6M $6M
Other Common Equity Adj -$87M -$62M -$32M -$33M -$17M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.7B $10B $10.4B $10B $11B
 
Total Liabilities and Equity $35.9B $35.2B $37.8B $40.2B $44.5B
Cash and Short Terms $994M $845M $662M $619M $1.9B
Total Debt $15.8B $13.9B $16.5B $19.1B $22.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$773M $1.5B $1.1B $917M $1B
Depreciation & Amoritzation $1.2B $1.3B $1.3B $1.4B $1.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $114M -$17M -$480M $349M -$111M
Change in Inventories $9M -$140M -$259M $167M $42M
Cash From Operations $2B $22M $1.8B $3.9B $2.1B
 
Capital Expenditures $2.6B $3.2B $4.4B $4.4B $4.5B
Cash Acquisitions $1.2B $22M $2.1B $144M --
Cash From Investing -$1.3B -$1.9B -$1.6B -$4.2B -$4.5B
 
Dividends Paid (Ex Special Dividend) -$529M -$492M -$489M -$535M -$522M
Special Dividend Paid
Long-Term Debt Issued $1.8B $4.5B $2.5B $6B $4B
Long-Term Debt Repaid -$3.5B -$3.1B -$2.4B -$4.3B -$1.6B
Repurchase of Common Stock -- -- -- -$800M --
Other Financing Activities -$14M -$43M -$43M -$80M -$63M
Cash From Financing -$834M $1.9B -$345M $374M $2.3B
 
Beginning Cash (CF) $271M $167M $254M $91M $109M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$104M $87M -$163M $18M -$79M
Ending Cash (CF) $167M $254M $91M $109M $30M
 
Levered Free Cash Flow -$601M -$3.1B -$2.6B -$524M -$2.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $363M $531M $325M $350M $297M
Depreciation & Amoritzation $307M $318M $319M $363M $363M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $32M -$200M $364M -$38M -$85M
Change in Inventories $99M $132M $95M $93M $110M
Cash From Operations -$1.7B $580M $1.7B $538M $410M
 
Capital Expenditures $594M $846M $1.1B $845M $1B
Cash Acquisitions -- $2.1B -- -- $1.2B
Cash From Investing -$604M $1.9B -$1.2B -$844M -$234M
 
Dividends Paid (Ex Special Dividend) -$136M -$131M -$144M -$126M -$143M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.8B $792M $3B $555M $1.2B
Long-Term Debt Repaid -$388M -$3.3B -$3.4B -$22M -$11M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$24M -$14M -$39M -$30M -$24M
Cash From Financing $2.3B -$2.6B -$519M $376M $1.1B
 
Beginning Cash (CF) $167M $254M $91M $109M $30M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -$107M $39M $70M $1.2B
Ending Cash (CF) $167M $147M $130M $179M $1.3B
 
Levered Free Cash Flow -$2.3B -$266M $590M -$307M -$628M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $789M $1.7B $851M $942M $966M
Depreciation & Amoritzation $1.2B $1.3B $1.3B $1.4B $1.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$103M -$249M $84M -$53M -$158M
Change in Inventories -$2M -$107M -$296M $165M $59M
Cash From Operations -$348M $2.3B $2.9B $2.7B $2B
 
Capital Expenditures $2.5B $3.4B $4.7B $4.1B $4.7B
Cash Acquisitions $1.2B $2.1B $15M $144M $1.2B
Cash From Investing -$1.2B $687M -$4.7B -$3.9B -$3.9B
 
Dividends Paid (Ex Special Dividend) -$478M -$487M -$502M -$517M -$539M
Special Dividend Paid
Long-Term Debt Issued $3.6B $2.5B $4.8B $3.6B $4.6B
Long-Term Debt Repaid -$3B -$6B -$2.4B -$915M -$1.6B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$34M -$33M -$68M -$71M -$57M
Cash From Financing $1.5B -$3B $1.8B $1.3B $2.9B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -$20M -$17M $49M $1.1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$2.9B -$1.1B -$1.8B -$1.4B -$2.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $363M $531M $325M $350M $297M
Depreciation & Amoritzation $307M $318M $319M $363M $363M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $32M -$200M $364M -$38M -$85M
Change in Inventories $99M $132M $95M $93M $110M
Cash From Operations -$1.7B $580M $1.7B $538M $410M
 
Capital Expenditures $594M $846M $1.1B $845M $1B
Cash Acquisitions -- $2.1B -- -- $1.2B
Cash From Investing -$604M $1.9B -$1.2B -$844M -$234M
 
Dividends Paid (Ex Special Dividend) -$136M -$131M -$144M -$126M -$143M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.8B $792M $3B $555M $1.2B
Long-Term Debt Repaid -$388M -$3.3B -$3.4B -$22M -$11M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$24M -$14M -$39M -$30M -$24M
Cash From Financing $2.3B -$2.6B -$519M $376M $1.1B
 
Beginning Cash (CF) $167M $254M $91M $109M $30M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -$107M $39M $70M $1.2B
Ending Cash (CF) $167M $147M $130M $179M $1.3B
 
Levered Free Cash Flow -$2.3B -$266M $590M -$307M -$628M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock